Food and Drug Administration approved Genentech’s “Avastin” for the treatment of advanced breast Cancer. Avastin was already got FDA approval for treating advanced Colon and non-small cell Lung cancer. According to the Genentech Company, Avastin in combination with Paclitaxel chemotherapy will rise survival period in metastatic breast cancer patients. Why FDA took this decision [...]
Taxotere approved for head and neck cancer by FDA
October 2, 2007 By Leave a Comment
French Pharma Company Sanofil-Aventis’s Taxotere (Docetaxel) got US FDA (Food and Drug Administration) approval for treating head and neck cancer. FDA approved Docetaxel for treating locally advanced head and neck cancer prior to chemotherapy and surgery. Taxotere is used in combination therapy along with cisplatin and 5-fluouracil for treating unresectable advanced squamous [...]
Evista for Breast Cancer in postmenopausal women
September 19, 2007 By Leave a Comment
Evista (Raloxifene) was approved for Breast cancer treatment by Food and Drug administration for some post-menopausal women. After Tamoxifen, Evista is the second drug approved for breast cancer treatment. Evista should not be prescribed for all women because of serious side effects. Evista is advised for treatment in two groups of women [...]
Recent Comments